Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.

Neuropsychiatr Dis Treat · 2016 · PMC4770062 · PMID 26966361

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

narrowly missed statistical significanceP =0.051so close (0.05 < p ≤ 0.1)

41 Duloxetine appeared to be superior to placebo in improving the 17-item HAMD (HAMD 17 ) work/activities scores at week 8 in one trial but not in another, although it narrowly missed statistical significance in the latter ( P =0.051).

also in 227 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.